ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1012

Disparities in Time to Diagnosis for Radiographic Axial Spondyloarthritis

Renato Ferrandiz1, Gabriela Rabasa2, Sarah Gasman3, Brooke Mcginley4, Rachael Stovall5, S. Reza Jafarzadeh6, Jean Liew6 and Maureen Dubreuil7, 1North Alabama Medical Center, Florence, AL, 2Department of Developmental Medicine, Boston Children's Hospital, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Boston University, Boston, MA, 5University of Washington, Seattle, WA, 6Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 7Section of Rheumatology, Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Access to care, Ankylosing spondylitis (AS), Disparities

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Healthcare Disparities in Rheumatology Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Radiographic axial spondyloarthritis (r-axSpA; formerly ankylosing spondylitis) has an average diagnostic delay of 7 years, which can lead to a diminished quality of life and disability if not promptly diagnosed and treated. While the impact of sex or gender on time to diagnosis has received considerable attention, the role of social determinants of health contributing to this delay remains understudied. We assessed whether time from the initial clinical documentation of r-axSpA symptoms to r-axSpA diagnosis varies based on sex, race, ethnicity, or the presence of social need.

Methods: We studied patients with r-axSpA using electronic health records from Boston Medical Center from 2000 to 2022. The cohort was built with the Observational Health Data Sciences and Informatics (OHDSI) network. We included adults with r-axSpA defined as 1 or more ICD-9 or 10 codes for r-axSpA who had outpatient visit information for > 12 months prior to r-axSpA diagnosis. For the primary analysis, we assessed the time from back pain/spinal pain to r-axSpA diagnosis and secondarily, the time to r-axSpA from either back/spine pain, peripheral arthritis, psoriasis, inflammatory bowel disease or uveitis. We extracted data on sex, patient-reported race, ethnicity, and documentation of any social need from an institutional validated questionnaire. We employed parametric survival models, accelerated failure time, to explore the average time to r-axSpA diagnosis, (1) from first diagnosis of back/spinal pain and (2) from any r-axSpA -related condition in the presence of unmet social needs.

Results: We included 404 patients with back pain or an r-axSpA -associated condition prior to r-axSpA diagnosis. Of these patients, 61 had at least one social need (mean age 49, 38.6 % female), with 25.5% of them identifying as Black and 31.1% as other or unknown race (Table). Patients with a documented social need had a 21% increase in time from back pain to r-axSpA diagnosis (95% CI 0.93, 1.56; Figure), adjusting for sex, race, and ethnicity. In the model for any r-axSpA -related condition, time to diagnosis increased similarly by 21% (95% CI 0.92, 1.57). Given that mean time to r-axSpA diagnosis was 34 months among those without social need, these findings indicate that a social need increased the time to r-axSpA diagnosis by 7 months, after accounting for age and sex.

Conclusion: This study reveals a trend toward diagnostic delay in r-axSpA related to social need, sex, race, and ethnicity. Future studies should focus on referral strategies to enable prompt diagnosis and optimize care.

Supporting image 1

Table. Demographics and baseline characteristic of r-axSpA patients with any first clinically defined r-axSpA symptom (n=404)
*Abbreviations: SD, standard deviation; IQR, interquartile range; NSAID, nonsteroidal anti-inflammatory drugs; TNFi, tumor necrosis factor inhibitor; JAKib, Janus kinase inhibitor; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ED, emergency department

†Based on THRIVE questionnaire addressing categories of: housing stability, food security, transportation access, medication affordability, employment status, education status, and caregiver status.

Supporting image 2

Figure. Mean time to r-axSpA diagnosis: Influence of age, sex, race, ethnicity, and presence of social needs
*The dotted line at 1 indicates that there is no difference in the average time it takes for the event to occur with an increase in the value of the risk factor. For example: those with social needs present have, on average, a 21% longer time to diagnosis compared to those without social needs, accounting for age, sex, race, and ethnicity.


Disclosures: R. Ferrandiz: None; G. Rabasa: None; S. Gasman: None; B. Mcginley: None; R. Stovall: None; S. Jafarzadeh: None; J. Liew: None; M. Dubreuil: Amgen, 2, Pfizer, 5, UCB Pharma, 2.

To cite this abstract in AMA style:

Ferrandiz R, Rabasa G, Gasman S, Mcginley B, Stovall R, Jafarzadeh S, Liew J, Dubreuil M. Disparities in Time to Diagnosis for Radiographic Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/disparities-in-time-to-diagnosis-for-radiographic-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disparities-in-time-to-diagnosis-for-radiographic-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology